脂肪肝
血脂异常
脂质代谢
非酒精性脂肪肝
脂肪生成
酒精性脂肪肝
高脂血症
激素
甾醇调节元件结合蛋白
肝损伤
药品
内分泌学
传统医学
医学
药理学
疾病
内科学
中医药
脂肪性肝炎
生物
糖尿病
胆固醇
甾醇
作者
Jun Zhu,Hongwei Yi,Wei Huang,Tao Pang,Huiping Zhou,Xudong Wu
标识
DOI:10.1016/s1875-5364(20)30017-0
摘要
The liver is an important metabolic organ and controls lipid, glucose and energy metabolism. Dysruption of hepatic lipid metabolism is often associated with fatty liver diseases, including nonalcoholic fatty liver disease (NAFLD), alcoholic fatty liver diseases (AFLD) and hyperlipidemia. Recent studies have uncovered the contribution of hormones, transcription factors, and inflammatory cytokines to the pathogenesis of dyslipidemia and fatty liver diseases. Moreover, a significant amount of effort has been put to examine the mechanisms underlying the potential therapeutic effects of many natural plant products on fatty liver diseases and metabolic diseases. We review the current understanding of insulin, thyroid hormone and inflammatory cytokines in regulating hepatic lipid metabolism, focusing on several essential transcription regulators, such as Sirtuins (SIRTs), Forkhead box O (FoxO), Sterol-regulatory element-binding proteins (SREBPs). We also discuss a few representative natural products with promising thereapeutic effects on fatty liver disease and dyslipidemia.
科研通智能强力驱动
Strongly Powered by AbleSci AI